Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.31M | $3.0M | 3.88% | -- | 2026-03-31 |
| Laird Norton Wetherby Trust Company, LLC | 566.3K | $1.0M | 1.67% | -21.7K | 2026-03-31 |
| UBS Group AG | 551.6K | $1.0M | 1.63% | +92.6K | 2026-03-31 |
| D.A. DAVIDSON & CO. | 539.3K | $1.0M | 1.59% | -- | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 364.7K | -- | 1.08% | +13.8K | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 191.1K | -- | 0.56% | -- | 2026-03-31 |
| MARSHALL WACE, LLP | 173.2K | -- | 0.51% | +132.6K | 2026-03-31 |
| BlackRock, Inc. | 170.1K | -- | 0.50% | +6.1K | 2026-03-31 |
| STATE STREET CORP | 159.0K | -- | 0.47% | -- | 2026-03-31 |
| GSA CAPITAL PARTNERS LLP | 98.8K | -- | 0.29% | +16.7K | 2026-03-31 |
